Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laise Rodrigues Reis

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
NPJ Vaccines|December 22, 2025
Integrated analysis of humoral and memory B-cell responses reveals distinct immune landscapes shaped by influenza vaccine platformsLaise Rodrigues Reis, Ted M Ross
Frontiers in Immunology|May 6, 2026
Next-generation intranasal influenza vaccines: mechanisms, platforms, and translational progressLaise Rodrigues Reis, Ted M Ross
Journal of Immunology (Baltimore, Md. : 1950)|October 30, 2025
Comparative analysis of cellular immune responses to four seasonal inactivated influenza vaccines in younger and older adultsVanessa Silva-Moraes, Laise Rodrigues Reis, Ted M Ross
Frontiers in Immunology|December 5, 2024
B-cell dynamics underlying poor response upon split-inactivated influenza virus vaccinationLaise Rodrigues Reis, Vanessa Silva-Moraes, Andréa Teixeira-Carvalho, et al.
Emerging Infectious Diseases|July 13, 2019
17DD Yellow Fever Revaccination and Heightened Long-Term Immunity in Populations of Disease-Endemic Areas, BrazilAna Carolina Campi-Azevedo, Vanessa Peruhype-Magalhāes, Jordana Grazziela Coelho-Dos-Reis, et al.
Microorganisms|November 27, 2024
Phenotypic Timeline Kinetics, Integrative Networks, and Performance of T- and B-Cell Subsets Associated with Distinct Clinical Outcome of Severe COVID-19 PatientsGabriela de Oliveira, Ismael Artur Costa-Rocha, Nani Oliveira-Carvalho, et al.
Frontiers in Immunology|July 12, 2019
Duration of Humoral and Cellular Immunity 8 Years After Administration of Reduced Doses of the 17DD-Yellow Fever VaccineIsmael Artur da Costa-Rocha, Ana Carolina Campi-Azevedo, Vanessa Peruhype-Magalhães, et al.
Frontiers in Immunology|November 8, 2019
Corrigendum: Duration of Humoral and Cellular Immunity 8 Years After Administration of Reduced Doses of the 17DD-Yellow Fever VaccineIsmael Artur da Costa-Rocha, Ana Carolina Campi-Azevedo, Vanessa Peruhype-Magalhães, et al.
Vaccine|December 31, 2021
Exploratory study of humoral and cellular immunity to 17DD Yellow Fever vaccination in children and adults residents of areas without circulation of Yellow Fever VirusLaise Rodrigues Reis, Ismael Artur da Costa-Rocha, Ana Carolina Campi-Azevedo, et al.
Frontiers in Immunology|October 17, 2019
Short-Lived Immunity After 17DD Yellow Fever Single Dose Indicates That Booster Vaccination May Be Required to Guarantee Protective Immunity in ChildrenAna Carolina Campi-Azevedo, Laise Rodrigues Reis, Vanessa Peruhype-Magalhães, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
NPJ Vaccines|December 22, 2025
Integrated analysis of humoral and memory B-cell responses reveals distinct immune landscapes shaped by influenza vaccine platformsLaise Rodrigues Reis, Ted M Ross
Frontiers in Immunology|May 6, 2026
Next-generation intranasal influenza vaccines: mechanisms, platforms, and translational progressLaise Rodrigues Reis, Ted M Ross
Journal of Immunology (Baltimore, Md. : 1950)|October 30, 2025
Comparative analysis of cellular immune responses to four seasonal inactivated influenza vaccines in younger and older adultsVanessa Silva-Moraes, Laise Rodrigues Reis, Ted M Ross
Frontiers in Immunology|December 5, 2024
B-cell dynamics underlying poor response upon split-inactivated influenza virus vaccinationLaise Rodrigues Reis, Vanessa Silva-Moraes, Andréa Teixeira-Carvalho, et al.
Emerging Infectious Diseases|July 13, 2019
17DD Yellow Fever Revaccination and Heightened Long-Term Immunity in Populations of Disease-Endemic Areas, BrazilAna Carolina Campi-Azevedo, Vanessa Peruhype-Magalhāes, Jordana Grazziela Coelho-Dos-Reis, et al.
Microorganisms|November 27, 2024
Phenotypic Timeline Kinetics, Integrative Networks, and Performance of T- and B-Cell Subsets Associated with Distinct Clinical Outcome of Severe COVID-19 PatientsGabriela de Oliveira, Ismael Artur Costa-Rocha, Nani Oliveira-Carvalho, et al.
Frontiers in Immunology|July 12, 2019
Duration of Humoral and Cellular Immunity 8 Years After Administration of Reduced Doses of the 17DD-Yellow Fever VaccineIsmael Artur da Costa-Rocha, Ana Carolina Campi-Azevedo, Vanessa Peruhype-Magalhães, et al.
Frontiers in Immunology|November 8, 2019
Corrigendum: Duration of Humoral and Cellular Immunity 8 Years After Administration of Reduced Doses of the 17DD-Yellow Fever VaccineIsmael Artur da Costa-Rocha, Ana Carolina Campi-Azevedo, Vanessa Peruhype-Magalhães, et al.
Vaccine|December 31, 2021
Exploratory study of humoral and cellular immunity to 17DD Yellow Fever vaccination in children and adults residents of areas without circulation of Yellow Fever VirusLaise Rodrigues Reis, Ismael Artur da Costa-Rocha, Ana Carolina Campi-Azevedo, et al.
Frontiers in Immunology|October 17, 2019
Short-Lived Immunity After 17DD Yellow Fever Single Dose Indicates That Booster Vaccination May Be Required to Guarantee Protective Immunity in ChildrenAna Carolina Campi-Azevedo, Laise Rodrigues Reis, Vanessa Peruhype-Magalhães, et al.
Pageof 2